COMMUNIQUÉS West-GlobeNewswire

TiGenix Business and Financial Update for the First Half 2017
19/09/2017
PRESS RELEASE Regulated information TiGenix Business and Financial Update for the First Half 2017 (Conference call and webcast today at 15:00 CET) Leuven (BELGIUM) - September 19, 2017, 07:00h CET - TiGenix NV (Euronext [...]
Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017
19/09/2017
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017 (Conférence téléphonique et webdiffusion aujourd'hui à 15h CET) Louvain (BELGIQUE) - 19 [...]
Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses
18/09/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]
Sanofi : Disclosure of trading in own shares
18/09/2017
Reporting EN This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Sanofi : Déclaration des transactions sur actions propres
18/09/2017
Reporting FR This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Ossur Hf : Transactions in relation to share buyback program
18/09/2017
Announcement from Össur hf. No. 67/2017 Reykjavík, 18 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Novo Nordisk A/S - Share repurchase programme
18/09/2017
Bagsværd, Denmark, 18 September 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management
18/09/2017
The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today [...]
AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research
18/09/2017
Uppsala September 18, 2017 PRESS RELEASE New application for AroCell TK 210 ELISA opens new opportunities for drug development research AroCell AB (publ) announces today that an abstract submitted by Kiran Kumar [...]
Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis
18/09/2017
Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and Health-related [...]
Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting
18/09/2017
LOS ANGELES, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations [...]
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases
18/09/2017
PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® [...]
Solon Eiendom ASA : Primary insider notification
18/09/2017
(Oslo, Norway, 15 September 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 155,259 shares in Solon Eiendom ASA at a price of NOK 17.9561 per [...]
Cambridge Medical Robotics closes Series A fundraise with further $26 million
18/09/2017
Cambridge Medical Robotics Limited ("CMR" or the "Company") Cambridge Medical Robotics closes Series A fundraise with further $26 million Cambridge, UK, 18 September 2017 : Cambridge Medical Robotics Ltd, the private [...]
Saniona AB: Saniona reports encouraging start for tesofensine Phase 3 study
18/09/2017
PRESS RELEASE September 18, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that Saniona's partner, Medix, has recruited 150 out of the planned 372 patients in the study during the [...]
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases
18/09/2017
PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® [...]
ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)
18/09/2017
Leuven, Belgium, 18 th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease, announced today that [...]
INNATE PHARMA,: Premier semestre 2017 : Nouvelles données cliniques et enrichissement du portefeuille
18/09/2017
PREMIER SEMESTRE 2017 : NOUVELLES DONNÉES CLINIQUES ET ENRICHISSEMENT DU PORTEFEUILLE Trésorerie, équivalents de trésorerie et actifs financiers [1] s'élevant à 204,1 millions d'euros au 30 juin 2017 Importants progrès [...]
INNATE PHARMA, First half of 2017: delivering key clinical data and strengthening the pipeline
18/09/2017
first half of 2017: DELIVERING KEY CLINICAL Data and strengthening the Pipeline Cash, cash equivalents and financial assets [1] for the Company amounted to €204.1m (million euros) as of June 30, 2017 Significant [...]

Pages